MedPath

A single-blind randomised controlled trial to determine the effectiveness of group Cognitive Behaviour Therapy (CBT) in the prevention of depression in high risk adolescents

Not Applicable
Completed
Conditions
Depression
Mental and Behavioural Disorders
Registration Number
ISRCTN19083628
Lead Sponsor
niversity of Bath (UK)
Brief Summary

1. 2010 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/21114808 2. 2012 results in: https://www.ncbi.nlm.nih.gov/pubmed/23043090 (added 08/05/2019) 3. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/24172024 4. 2014 cost-effectiveness results in: http://www.ncbi.nlm.nih.gov/pubmed/24813670

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
5030
Inclusion Criteria

All children aged 13-16 attending participating schools (n = 8-12)

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in depression symptoms as assessed by the short form Mood and Feelings Questionnaire at 12 months follow-up.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Changes in self-image and negative thoughts. These will be assessed at 12 months by the following questionnaires:<br> 1.1. Self Image Profiles (SIP-A). An easily competed 25-item scale for adolescents assesses how they perceive themselves and how they would like to be. Twelve items assess positive attributes (e.g. confident, fun to be with), twelve assess negative attributes (e.g. annoying, moody) and one is neutral (i.e. feel different from others).<br> 1.2. Children's Automatic Thoughts Scale (CATS). This self-completed scale assesses a range of negative self statements in children and young people aged 7-16. For each item the child is asked to rate whether they have had a similar thought over the past week. Each item is rated as not at all (scores 0), sometimes (scores 1), fairly often (scores 2), often (scores 3) or all the time (scores 4). The 10-item personal failure sub-scale will be used.<br> 2. Cost effectiveness at 12 months<br>
© Copyright 2025. All Rights Reserved by MedPath